| [Corporate Advisory] Advice on the issuance of convertible preferred shares by a bio company engaging in developing new medicines |
7/17/2018 |
|
[Corporate Advisory] Advice on the issuance of convertible preferred shares by a bio company engaging in developing new medicines.
|
|
Practice
Professionals 
|